LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED) concerning the Company’s and its officers’ possible violations of federal securities laws. Glancy Binkow & Goldberg is preparing a class action to recover damages on behalf of injured Globus shareholders.
On April 22, 2015 the Company announced that its auditors, KPMG LLP, had declined to stand for reelection as auditor of the Company’s financial statements. The Company stated in relevant part, “[o]n April 16, 2015, KPMG LLP ("KPMG") orally notified Globus Medical, Inc. (the "Company") that upon the completion of KPMG's review of the Company's consolidated financial statements for the quarterly reporting period ended March 31, 2015 and the filing of the related Quarterly Report on Form 10-Q, KPMG declines to stand for reelection as the independent registered public accounting firm for the Company. KPMG's decision was accepted by the audit committee of the Company's board of directors.” On this news, shares of Globus fell on April 23, 2015, as much as $1.33 per share during intraday trading, on unusually high volume.
If you purchased shares of Globus prior to April 23, 2015, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.